Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Safety and effectiveness of apixaban compared to warfarin in dialysis patients
2018
Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction
2011
Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
2011
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents
2007
Newer Pharmacotherapy in Patients Undergoing Percutaneous Coronary Interventions: A Guide for Pharmacists and Other Health Care Professionals
2006
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
2008 StandoutNobel
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Myasthenia Gravis
2016 Standout
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Discrimination of patients with type 2 myocardial infarction
2017
n–3 Fatty Acids in Cardiovascular Disease
2011
Variability in Individual Responsiveness to Clopidogrel
2007
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Stent Thrombosis
2010
Mammalian lipoxygenases and their biological relevance
2014
Dynamic assessment of 'valvular reserve capacity' in patients with rheumatic mitral stenosis
2011
Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
2011
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction Towards an understanding of factors influencing clinical practice
1998
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002 Standout
Dynamic control over cell adhesive properties using molecular-based surface engineering strategies
2009 StandoutNobel
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents
2013
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients
2007
CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention
2011
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty
2009
Obesity
2005 Standout
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey
2006
TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: A meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients
2012
Platelet Activation and Atherothrombosis
2007 Standout
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
2008
Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis
2004
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Antiplatelet Drugs
2008
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
2005
Obesity and Altered Aspirin Pharmacology
2017
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Evaluation of polymer and self-assembled monolayer-coated silicone surfaces to reduce neural cell growth
2005
Metabolic syndrome update
2015
Clopidogrel–Drug Interactions
2011
Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics<SUBTITLE>The PCI-CLARITY Study</SUBTITLE>
2005
Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis
2007
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
2008
The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients
2012
Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies
2017
Risk scores in acute coronary syndrome and percutaneous coronary intervention: A review
2013
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis
2010
Diesel exhaust inhalation increases thrombus formation in man
2008
Abciximab
2003
Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes
2008
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation
2009
Current Options in Platelet Function Testing
2006
Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization — A review of current strategies
2009
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study fn1fn1This study was supported by a University-Industry grant from the Medical Research Council, Ottawa, Ontario, Canada and Bristol Myers Squibb, Montreal, Quebec, Canada.
1997
Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
2009
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
2012
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
new understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging
2003
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE
2010
A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel
2004
Efficacy of High-Dose Atorvastatin Loading Before Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
2010
Platelet-Active Drugs
2001
Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction
2002
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
Normalization of platelet reactivity in clopidogrel‐treated subjects
2006
Nanocomposite Containing Bioactive Peptides Promote Endothelialisation by Circulating Progenitor Cells: An In vitro Evaluation
2006
Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review
2007
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Characteristics and Outcomes in a Contemporary Group of Patients With Suspected Significant Mitral Stenosis Undergoing Treadmill Stress Echocardiography
2019
Patterned Hydrogels for Controlled Platelet Adhesion from Whole Blood and Plasma
2010 StandoutNobel
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel
2006
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
The Outcome of Coronary Artery Bypass Grafting Surgery among Patients Hospitalized with Acute Coronary Syndrome: The Euro Heart Survey of Acute Coronary Syndrome Experience
2004
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Randomized clinical trial of the antiplatelet effects of aspirin–clopidogrel combination versus aspirin alone after lower limb angioplasty
2004
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Coexisting Polymorphisms of P2Y12 and CYP2C19 Genes as a Risk Factor for Persistent Platelet Activation With Clopidogrel
2008
Sudden Cardiac Death
1998 Standout
2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
2012
Coronary Microembolization
2009
Biofunctionalization of Biomaterials for Accelerated in Situ Endothelialization: A Review
2008
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease
2012
Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery
2008
Statins and the neuromuscular system: a neurologist's perspective
2014
Recent Developments in the Chemistry of Cubic Polyhedral Oligosilsesquioxanes
2010 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
2015
Atherosclerotic Plaque Healing
2020
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Clopidogrel Response Variability and Future Therapies
2006
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Eli I. Lev being referenced
Effect of Clopidogrel Pretreatment on Angiographic and Clinical Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction
2007
Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel
2006
Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease
2007
Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
1995
Major bleeding complicating contemporary primary percutaneous coronary interventions—incidence, predictors, and prognostic implications
2009
Distribution of serum creatine kinase activity in young healthy persons
1999
Clinical experiences using the FilterWire EX for distal embolic protection during complex percutaneous coronary interventions
2004
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control
2001
Pharmacology of Antiplatelet Agents
2013
Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients
2006
The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease
2015
Platelet reactivity and response to aspirin in subjects with the metabolic syndrome
2008
Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation
2010
Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function
2001
Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction
2005
Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention
2005
Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirin
2007
Effect of Previous Treatment With Statins on Outcome of Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
2008
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia
2013
Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns
2003
Value of exercise echocardiography in rheumatic mitral stenosis with and without significant mitral regurgitation
2004
Comparison of outcomes up to six months of Heparin-Coated with noncoated stents after percutaneous coronary intervention for acute myocardial infarction
2004
Comparison of the Predictive Value of Four Different Risk Scores for Outcomes of Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
2008
Role of Reticulated Platelets and Platelet Size Heterogeneity on Platelet Activity After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease
2008
Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction
2015
Acute Antithrombotic Effect of a Front-Loaded Regimen of Clopidogrel in Patients With Atherosclerosis on Aspirin
2000
The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery
2009
Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix
2006
Testing Platelet Activation With a Shear-Dependent Platelet Function Test Versus Aggregation-Based Tests
2001